-
-
-
-
-
-
-
Fate Therapeutics (FATE) PT Raised to $7 at H.C. Wainwright
-
-
-
-
-
-
-
Wedbush Upgrades Fate Therapeutics (FATE) to Outperform
-
-
-
-
-
-
-
Fate Therapeutics (FATE) PT Lowered to $2.20 at BofA Securities
-
-
-
-
-
-
-
Fate Therapeutics (FATE) PT Lowered to $3 at Stifel
-
-
-
-
-
-
-
Oppenheimer Reiterates Perform Rating on Fate Therapeutics (FATE)
-
-
-
-
-
-
-
BMO Capital Reiterates Market Perform Rating on Fate Therapeutics (FATE)
-
-
-
-
-
-
-
Form SC 13G/A FATE THERAPEUTICS INC Filed by: ARK Investment Management LLC
-
413,079 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

